Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$618M |
| 2 |
Vale
VALE
|
+$332M |
| 3 |
CELG
Celgene Corp
CELG
|
+$309M |
| 4 |
CME Group
CME
|
+$306M |
| 5 |
Amazon
AMZN
|
+$290M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$435M |
| 2 |
Meta Platforms (Facebook)
META
|
+$342M |
| 3 |
Crown Castle
CCI
|
+$244M |
| 4 |
SLB Ltd
SLB
|
+$229M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.17% |
| 2 | Technology | 14.41% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Financials | 10.51% |
| 5 | Real Estate | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UBP
2701
DELISTED
Urstadt Biddle Properties Inc.
UBP
| $930K | ﹤0.01% |
55,700
+1,800
| +3% | +$29.7K |
|
|
IMBI
2702
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $929K | ﹤0.01% |
198,258
-12,968
| -6% | -$63.5K |
|
2703
First Community Corp
FCCO
$321M
| $927K | ﹤0.01% |
48,600
+8,000
| +20% | +$159K |
|
|
VNTR
2704
DELISTED
Venator Materials PLC
VNTR
| $927K | ﹤0.01% |
164,900
-738,900
| -82% | -$3.93M |
|
2705
KALA BIO
KALA
$14.1M
| $926K | ﹤0.01% |
45
-72
| -62% | -$1.28M |
|
2706
Varex Imaging
VREX
$472M
| $925K | ﹤0.01% |
27,300
-33,600
| -55% | -$1.02M |
|
2707
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.76B
| $924K | ﹤0.01% |
+32,364
| New | +$909K |
|
2708
Achieve Life Sciences
ACHV
$659M
| $923K | ﹤0.01% |
14,283
+1,690
| +13% | +$68.3K |
|
|
MRSN
2709
DELISTED
Mersana Therapeutics
MRSN
| $918K | ﹤0.01% |
+6,981
| New | +$878K |
|
|
ARAV
2710
DELISTED
Aravive, Inc. Common Stock
ARAV
| $917K | ﹤0.01% |
130,248
+1,246
| +1% | +$6.5K |
|
2711
Dollar Tree
DLTR
$24.4B
| $914K | ﹤0.01% |
+8,703
| New | +$854K |
|
2712
PPG Industries
PPG
$24.6B
| $914K | ﹤0.01% |
8,100
-14,000
| -63% | -$1.5M |
|
2713
Yatra Online
YTRA
$52.7M
| $911K | ﹤0.01% |
185,600
+400
| +0.2% | +$1.85K |
|
2714
Veritone
VERI
$101M
| $910K | ﹤0.01% |
+175,000
| New | +$975K |
|
2715
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $909K | ﹤0.01% |
+17,200
| New | +$898K |
|
2716
State Street SPDR ICE Preferred Securities ETF
PSK
$692M
| $908K | ﹤0.01% |
21,274
+7,884
| +59% | +$330K |
|
2717
Canadian Solar
CSIQ
$1.02B
| $907K | ﹤0.01% |
+48,702
| New | +$1M |
|
|
HNP
2718
DELISTED
Huaneng Power Intl, Inc.
HNP
| $905K | ﹤0.01% |
+39,100
| New | +$971K |
|
2719
John B. Sanfilippo & Son
JBSS
$967M
| $898K | ﹤0.01% |
12,500
-17,200
| -58% | -$1.15M |
|
2720
Franklin Electric
FELE
$4.63B
| $894K | ﹤0.01% |
+17,500
| New | +$862K |
|
|
ONIT
2721
Onity Group
ONIT
$309M
| $894K | ﹤0.01% |
32,749
-74,113
| -69% | -$2.09M |
|
2722
Solid Biosciences
SLDB
$794M
| $887K | ﹤0.01% |
+6,427
| New | +$1.61M |
|
2723
The Mosaic Company
MOS
$7.03B
| $882K | ﹤0.01% |
32,300
-1,140,600
| -97% | -$34.8M |
|
|
BCLI
2724
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $880K | ﹤0.01% |
13,510
+1,346
| +11% | +$76.6K |
|
2725
Ponce Financial Group
PDLB
$488M
| $876K | ﹤0.01% |
87,623
+42,998
| +96% | +$402K |
|
Similar funds
Renaissance Technologies's Q1 2019 Portfolio in Review
As of Q1 2019, Renaissance Technologies held 3,883 positions worth $110B, up 20% from $91.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Renaissance Technologies deployed $7.09B of net new capital in Q1 2019, opening 532 new positions and adding to 1,751 existing holdings. Its largest new stake was Amazon: 3,483,100 shares worth $310M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $342M trimmed.
- Renaissance Technologies's largest Q1 2019 buy was Amazon: 3,483,100 shares worth $310M.
- Renaissance Technologies added most to Starbucks in Q1 2019, an estimated $618M increase.
- Renaissance Technologies's biggest Q1 2019 reduction was Meta Platforms (Facebook), cutting an estimated $342M.
- Renaissance Technologies fully exited Apple in Q1 2019, selling an estimated $435M.
- Renaissance Technologies's ten largest holdings make up 8.7% of its $110B portfolio in Q1 2019.
- Renaissance Technologies opened 532 new positions and closed 465 in Q1 2019.
- Renaissance Technologies's portfolio value rose 20% quarter-over-quarter to $110B.
Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.